Targeting cancer metabolic pathways for improving chemotherapy and immunotherapy is a research paper published in Cancer Letters (2023). On theSindex it has a DataRank of 0. It has been cited 60 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: RO1CA223788
National Institutes of Health
Grant: RO1CA270623
National Institutes of Health
Grant: RO1CA278608
NCI NIH HHS
Grant: R01 CA239716
NCI NIH HHS
Grant: R01 CA278608
NCI NIH HHS
Grant: R01 CA270623
NCI NIH HHS
Grant: R01 CA223788
FWCI
6.41
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords